Publication | Open Access
Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase–Producing Enterobacterales During a Regional Outbreak
72
Citations
11
References
2020
Year
Clinical FeaturesBacterial PathogensNdm BacteremiaAntimicrobial StewardshipRegional OutbreakHealthcare-associated InfectionInfection ControlAntimicrobial ResistanceAerobic CulturingHospital EpidemiologyHealth SciencesAntimicrobial Drug DiscoveryClinical MicrobiologyEpidemiologyAntimicrobial SusceptibilityAntibioticsBloodstream InfectionsNew Delhi Metallo-β-lactamaseMicrobiologyMedicineFeasible Therapeutic Option
Limited data about New Delhi metallo-β-lactamase (NDM) bacteremia are available. Blood isolates from 40 patients with NDM bacteremia were studied for antibiotic susceptibility and whole-genomic sequencing. NDM bacteremia has high 30-day mortality. In most cases, aztreonam-avibactam is active in vitro. Ceftazidime-avibactam plus aztreonam may represent a feasible therapeutic option.
| Year | Citations | |
|---|---|---|
Page 1
Page 1